ScholarIQanswers from OpenAlex & ORCID
Bruce R. Blazar
ResearcherPublications, citations & collaboration network
Bruce R. Blazar is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bruce R. Blazar have?
ScholarIQindexed works
Bruce R. Blazar has 1,517 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bruce R. Blazar have?
ScholarIQcitation count
Bruce R. Blazar has 92,024 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bruce R. Blazar?
ScholarIQh-index
Bruce R. Blazar has an h-index of 149 in OpenAlex.
What is the i10-index of Bruce R. Blazar?
ScholarIQi10-index
Bruce R. Blazar has an i10-index of 766 in OpenAlex.
What is the ORCID of Bruce R. Blazar?
ScholarIQorcid
The ORCID for Bruce R. Blazar is on the source record.
What is the OpenAlex record for Bruce R. Blazar?
ScholarIQopenalex
The OpenAlex for Bruce R. Blazar is on the source record.
What are the most-cited papers on Bruce R. Blazar?
ScholarIQmost cited works
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
Jeffrey S. Miller, Yvette Soignier, Angela Panoskaltsis‐Mortari, Sarah A. McNearney, Gong Yun, Susan K. Fautsch, David H. McKenna, Chap T. Le, Todd E. DeFor, Linda J. Burns, Paul J. Orchard, Bruce R. Blazar, John E. Wagner, Arne Slungaard, Daniel J. Weisdorf, Ian J. Okazaki, Philip B. McGlave
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
John E. Wagner, Juliet N. Barker, Todd E. DeFor, K. Scott Baker, Bruce R. Blazar, Cindy Eide, Anne I. Goldman, John Kersey, William Krivit, Margaret L. MacMillan, Paul J. Orchard, Charles Peters, Daniel J. Weisdorf, Norma K.C. Ramsay, Stella M. Davies
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
David B. Miklos, Corey Cutler, Mukta Arora, Edmund K. Waller, Madan Jagasia, Iskra Pusic, Mary E.D. Flowers, Aaron C. Logan, Ryotaro Nakamura, Bruce R. Blazar, Yunfeng Li, Stephen Chang, Indu Lal, Jason A. Dubovsky, Danelle F. James, Lori Styles, Samantha Jaglowski
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
Shernan G. Holtan, Todd E. DeFor, Aleksandr Lazaryan, Nelli Bejanyan, Mukta Arora, Claudio G. Brunstein, Bruce R. Blazar, Margaret L. MacMillan, Daniel J. Weisdorf
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai‐Ho, Rohtesh S. Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N. Shah, Sunil Abhyankar, Carlos Bachier, John P. Galvin, Annie Im, Amelia Langston, Jane L. Liesveld, Mark Juckett, Aaron C. Logan, Levanto Schachter, Asif Alavi, Dianna S. Howard, Harlan W. Waksal, John L. Ryan, David Eiznhamer, Sanjay Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Z. Pavletic